Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Watch
Primary summary from verified readiness
- Confidence
- 60% · fresh
- Computed at
- 2026-07-21T20:38:57.221746+00:00
- Claimed
- 68
- Reported
- 61
- Verified
- 54
- Gap
- +14
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Critical
Decision
What the current evidence supports
Human editorial judgment · 2026-07-21
Track; not yet
- Why
- Regulatory and reimbursement rails are real (NMPA Class III certification plus an insurance billing code issued within 48 hours of approval), but the evidence base is currently a single commercial patient, a narrow single-function indication (cervical-SCI hand-grasp compensation via 8 electrode channels), unvalidated long-term device lifespan, and a heavy required rehabilitation regimen — too early to score above tracking.
- Next
- Re-assess after the second and third commercial implants are publicly reported and after Neuracle's STAR Market IPO prospectus discloses broader clinical-cohort outcome data (the 32-patient trial cohort behind this approval).
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 5
- Tier 1
- 0
- Tier 2
- 4
- Tier 3
- 1
- Supports
- 2
- Contradicts
- 2
- Context
- 1
- Latest observed
- 2026-07-18
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
- 2026-07-21 Reading moved from watch to watch.